[Ip-health] SAVE THE DATE: WHO, Unitaid & MPP Symposium at the IAS Conference in Paris - 25 July

Katie Moore kmoore at medicinespatentpool.org
Fri Jul 7 02:35:29 PDT 2017


SAVE THE DATE

WHO, Unitaid & MPP Symposium at the IAS 2017 Conference in Paris - 25 July at 18:30

The World Health Organization, <http://mm.optistarcontact.com/t/33627256/1306852290/63164824/1/63529/?x=47211ed8> Unitaid<http://mm.optistarcontact.com/t/33627256/1306852290/73929214/0/63529/?x=38f45c47> and the Medicines Patent Pool<http://mm.optistarcontact.com/t/33627256/1306852290/54413299/0/63529/?x=d74c2c64>, together with the governments of South Africa and France and the Global Fund to Fight AIDS, Tuberculosis and Malaria<http://mm.optistarcontact.com/t/33627256/1306852290/74215773/0/63529/?x=70f3705f>, are honoured to invite you to a satellite symposium during the 9th International AIDS Society Conference on HIV Science<http://mm.optistarcontact.com/t/33627256/1306852290/74215774/0/63529/?x=1c9fee6b>:

ACCELERATING ACCESS TO NEW HIV MEDICINES
IN LOW- AND MIDDLE-INCOME COUNTRIES

Tuesday 25 July 2017, 18:30 to 20:30, Maillot Room

Convention Centre, 2 Place de Porte Maillot, 75017 Paris, France

A light reception will be served after the symposium

New antiretrovirals (ARVs) and formulations have the potential of revolutionising adult and paediatric HIV treatment. However, their introduction and scale-up in low- and middle-income countries can be complex and take significant time. The satellite symposium will review new ARVs and new formulations, analyse the range of different challenges that need to be overcome to ensure rapid scale-up and discuss initiatives that are contributing to accelerating development, registration and access. Particular attention will be devoted to addressing regulatory challenges and existing programmes and initiatives to facilitate and speed in-country registration and market introduction.

More information on our website<http://mm.optistarcontact.com/t/33627256/1306852290/74215775/0/63529/?x=5e110fbe>

www.medicinespatentpool.org<http://mm.optistarcontact.com/t/33627256/1306852290/54967049/0/63529/?x=d29c488a>

About the Medicines Patent Pool

The Medicines Patent Pool is a United Nations-backed public health organisation working to increase access to HIV, hepatitis C and tuberculosis treatments in low- and middle-income countries. Through its innovative business model, the MPP partners with industry, civil society, international organisations, patient groups and other stakeholders to prioritise, forecast and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, the MPP has signed agreements with nine patent holders for twelve HIV antiretrovirals, one HIV technology platform, a tuberculosis treatment and two hepatitis C direct-acting antivirals. The MPP was founded and is funded by Unitaid.



 Katherine Moore| Head of Communications | Medicines Patent Pool
Website<http://www.medicinespatentpool.org/> | Newsletter<http://www.medicinespatentpool.org/news-room/newsletter/> | Twitter<http://twitter.com/MedsPatentPool> | LinkedIn<http://www.linkedin.com/company/medicines-patent-pool>
Tel: +41 22 533 5054 | Mobile: +41 79 825 4786
Email: kmoore at medicinespatentpool.org<mailto:kmoore at medicinespatentpool.org>



More information about the Ip-health mailing list